arrow_back Back Filing freshness 10-K Q4 FY2023 SEC EDGAR

download Export Data

NP Life Sciences Health Industry Group Inc.

ACAT

— Price unavailable

21 Visible periods

23 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Neutral

auto_awesome

Analytical Summary

NP Life Sciences Health Industry Group Inc. shows mixed fundamentals. Consider comparing against peers in the Industrials sector before making investment decisions.

Market Cap —

Dividend Yield —

Revenue Growth -78.3% ↘

Op. Margin -358.4% ↘

ROIC None

FCF / Share None

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close.

21-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$10.01K

↓ -78.3% —

Net Income Profit after all expenses

$-15.36K

↑ +59.2% —

Operating Margin Operating profit as % of sales

-358.4%

↓ -67.6% 28th

FCF / Share Free cash flow per share

$-0.00

↓ -8.7% —

Health Breakdown

Profitability ↑

Financial Health ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-Q ↗
Revenue Growth YoY (%)	-78.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1665%)	-57.3% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1246%)	614.9% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+12197%)	—	—	—	—	—	—	—	—	—	—	—	N/M	-25.0% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-600%)	—	—	—	—	—
Net Income Growth YoY (%)	N/M	-592.5% Weak ↓ Weak Declining Year-over-year change in net income	6504.4% Excellent ↑ Excellent Improving Year-over-year change in net income	N/M	-48.6% Weak ↓ Weak Declining Year-over-year change in net income	73.9% Excellent Excellent Year-over-year change in net income	N/M	-28.3% Weak ↓ Weak Declining Year-over-year change in net income	N/M	18.7% Good ↓ Good Declining Year-over-year change in net income	1.7% Caution ↓ Caution Declining Year-over-year change in net income	19.5% Good ↑ Good Improving Year-over-year change in net income	48.8% Excellent ↑ Excellent Improving Year-over-year change in net income	19.6% Good ↑ Good Improving Year-over-year change in net income	-983.9% Weak Weak Year-over-year change in net income	-1.4% Weak Weak Year-over-year change in net income	—	—	—	—	—
Revenue CAGR 3Y (%)	—	—	—	26.0% Excellent Excellent Compound annual revenue growth over 3 years	—	—	-13.3% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-Q ↗
Operating Margin (%) (%)	-358.4% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3086%)	-213.8% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1882%)	66.7% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+455%)	4.1% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-66%)	36.1% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+201%)	-13.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-211%)	7.2% Caution Caution Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-40%)	—	—	—	—	—	—	—	—	-200.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1774%)	—	—	-20.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-269%)	-148.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1338%)	—
Effective Tax Rate (%) (%)	56.8% Weak Weak Actual taxes paid relative to pre-tax income Optimal: 15-25%	6.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	-153.4% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2018%)	-215.1% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2788%)	66.5% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+731%)	4.1% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-49%)	36.1% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+351%)	-13.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-266%)	7.2% Caution Caution Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-10%)	—	—	—	—	—	—	—	—	-200.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2610%)	—	—	-21.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-369%)	-148.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1956%)	—
FCF Margin (%) (%)	-139.3% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-231.6% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-34.9% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	60.7% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	249.7% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	-138.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	-96.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-260.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	0.91x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.08x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	-0.52x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	14.91x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	6.92x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	0.16x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.09x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	1.20x Good Good Free cash flow relative to reported net income Optimal: > 1x	1.22x Good Good Free cash flow relative to reported net income Optimal: > 1x	—	—	0.69x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-1.78x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	4.47x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	1.75x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-Q ↗
Return on Invested Capital (%)	—	-110.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	84.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	4.7% Caution ↑ Caution Improving Return earned on debt + equity capital invested Optimal: > 10%	—	-158.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	10.4% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	-346.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	66.8% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-278.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-155.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-24.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-16.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-16.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-28.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.6% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-14.2% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-9.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—
Return on Capital (%) (%)	-46.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-39.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	49.5% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	0.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	13.0% Good ↑ Good Improving Operating profit relative to total assets Optimal: > 10%	-32.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	6.3% Caution ↑ Caution Improving Operating profit relative to total assets Optimal: > 10%	-125.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	84.0% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	-83.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-129.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-27.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-18.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-16.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-30.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-13.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-16.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	-11.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—
Return on Common Equity (%) (%)	—	-118.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-891%)	106.1% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+607%)	5.9% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-60%)	—	-200.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1434%)	13.2% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-12%)	—	84.5% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+464%)	—	-196.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1409%)	-30.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-303%)	-20.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-239%)	-20.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-236%)	-35.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-337%)	-14.7% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-198%)	-18.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-220%)	-11.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-177%)	—	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-Q ↗
Interest Coverage (x)	—	—	—	408.33x Excellent Excellent Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Debt (USD)	$-70.61K	$-84.55K	$-125.11K	$-140.08K	$-121.86K	$-6.95K	$-575.00	$-23.12K	$-27.99K	$-25.01K	$-40.73K	$-89.43K	$-118.61K	$-144.99K	$-168.52K	$-222.22K	$-242.93K	$-276.62K	—	—	$-200.00

📊 What does each share earn? 6 metrics

Metric	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-Q ↗
Revenue per Share (USD)	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	—	—	—	$0.00	—	—	—	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	—	$-0.00	$-0.00	$0.00	—	—	—	$-0.00	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.01	$0.01	—	—	—
Tangible Book Value per Share (USD)	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.01	$0.01	—	—	—
Basic Weighted Avg Shares (shares)	—	42.96M	42.96M	42.96M	—	42.96M	42.96M	42.96M	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 1 metrics

Metric	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-Q ↗
Total Equity (USD)	—	$31.74K	$67.11K	$20.54K	—	$2.72K	$8.16K	$7.08K	$38.17K	$5.90K	$26.86K	$79.61K	$103.85K	$125.51K	$151.14K	$204.79K	$234.91K	$277.24K	—	—	$-20.68K

📋 What is driving earnings? 3 metrics

Metric	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-Q ↗
Sales/Revenue/Turnover (USD)	$10.01K	$17.52K	$107.10K	$30.00K	$46.02K	$41.00K	$14.98K	—	—	—	—	—	$0.00	—	$0.00	$15.00K	$0.00	—	$23.00K	$20.00K	—
Net Income, GAAP (USD)	$-15.36K	$-37.67K	$71.19K	$1.22K	$16.60K	$-5.44K	$1.08K	$-31.09K	$32.27K	$-20.83K	$-52.74K	$-24.24K	$-21.66K	$-25.63K	$-53.65K	$-30.12K	$-42.32K	$-31.88K	$-4.95K	$-29.70K	—
Operating Cash Flow (USD)	$-13.94K	$-40.56K	$-37.33K	$18.22K	$114.91K	—	—	$-4.86K	$2.98K	—	—	$-29.18K	$-26.38K	—	—	$-20.71K	$75.14K	—	$-22.14K	$-52.12K	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 6 years · 21 quarters

NP Life Sciences Health Industry Group Inc.

Analytical Summary

21-Year Financial Trajectory

Health Breakdown

Statement lens

Benchmark Lens

Percentile Rankings

Peer Comparison

Compare ACAT with peers